Ability biologics is a seed startup. 1 investor tracked. Status: possibledead.
Ability biologics is a startup founded in 2014 based in the United States. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Ability Biologics develops protein therapeutics that aim to improve drug delivery and efficacy, focusing on treatments for cancer and inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.